These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35476107)

  • 41. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia.
    Ayoola EA; Want MA; Gadour MO; Al-Hazmi MH; Hamza MK
    J Med Virol; 2002 Mar; 66(3):329-34. PubMed ID: 11793384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.
    Jablonka A; Solbach P; Wöbse M; Manns MP; Schmidt RE; Wedemeyer H; Cornberg M; Behrens GMN; Hardtke S
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):939-945. PubMed ID: 28492419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative Seroprevalence of Hepatitis A And E Viruses in Blood Donors from Wielkopolska Region, West-Central Poland.
    Bura M; Łagiedo-Żelazowska M; Michalak M; Sikora J; Mozer-Lisewska I
    Pol J Microbiol; 2018 Mar; 67(1):113-115. PubMed ID: 30015433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.
    Traoré KA; Rouamba H; Nébié Y; Sanou M; Traoré AS; Barro N; Roques P
    PLoS One; 2012; 7(10):e48125. PubMed ID: 23110187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of hepatitis E virus IgG antibodies in patients from a referral unit of liver diseases in Salvador, Bahia, Brazil.
    Parana R; Cotrim HP; Cortey-Boennec ML; Trepo C; Lyra L
    Am J Trop Med Hyg; 1997 Jul; 57(1):60-1. PubMed ID: 9242319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy.
    Rapicetta M; Monarca R; Kondili LA; Chionne P; Madonna E; Madeddu G; Soddu A; Candido A; Carbonara S; Mura MS; Starnini G; Babudieri S
    Infection; 2013 Feb; 41(1):69-76. PubMed ID: 23264095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014].
    Yan BY; Zhang L; Lyu JJ; Feng Y; Liu JY; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):587-592. PubMed ID: 28693081
    [No Abstract]   [Full Text] [Related]  

  • 48. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
    Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unusual high prevalence of antibodies to hepatitis E virus in South Brazil.
    Zorzetto R; Klein RL; Erpen LMS; Klein BD; Giacobbo I; da Silveira RA; Frandoloso R; Kreutz LC
    FEMS Microbiol Lett; 2021 Jul; 368(13):. PubMed ID: 34196363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area].
    Cesur S; Akin K; Doğaroğlu I; Birengel S; Balik I
    Mikrobiyol Bul; 2002 Jan; 36(1):79-83. PubMed ID: 12476770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High prevalence of hepatitis E virus antibodies among blood donors in Southern Brazil.
    Passos-Castilho AM; de Sena A; Geraldo A; Spada C; Granato CF
    J Med Virol; 2016 Feb; 88(2):361-4. PubMed ID: 26211918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection and characterization of hepatitis E virus genotype 3 in HIV-infected patients and blood donors from southern Brazil.
    Moss da Silva C; Oliveira JM; Mendoza-Sassi RA; Figueiredo AS; Mota LDD; Nader MM; Gardinali NR; Kevorkian YB; Salvador SBS; Pinto MA; Martinez AMB
    Int J Infect Dis; 2019 Sep; 86():114-121. PubMed ID: 31279609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seroprevalence of anti-HEV IgG in 182 Polish patients.
    Bura M; Michalak M; Chojnicki M; Czajka A; Kowala-Piaskowska A; Mozer-Lisewska I
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():320-6. PubMed ID: 25748623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay.
    Tanaka E; Takeda N; Tian-Chen L; Orii K; Ichijo T; Matsumoto A; Yoshizawa K; Iijima T; Takayama T; Miyamura T; Kiyosawa K
    J Gastroenterol; 2001 May; 36(5):317-21. PubMed ID: 11388394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis E seroprevalence and associated factors in rural settlers in Central Brazil.
    Freitas NR; Teles SA; Caetano KAA; Matos MA; Carneiro MADS; Gardinali NR; Pinto MA; Martins RMB
    Rev Soc Bras Med Trop; 2017; 50(5):675-679. PubMed ID: 29160516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A community prevalence study of antibodies to hepatitis A and E in inner-city London.
    Bernal W; Smith HM; Williams R
    J Med Virol; 1996 Jul; 49(3):230-4. PubMed ID: 8818970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Detection of anti-HAV IgM and anti-HEV IgM in patients with sporadic acute hepatitis in Beijing between 1995-2000].
    Lu J; Zhao H; Mong Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):157-9. PubMed ID: 11436647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of a hepatitis E virus outbreak involving drinking water and sewage contamination in Shimla, India, 2015-2016.
    Tripathy AS; Sharma M; Deoshatwar AR; Babar P; Bharadwaj R; Bharti OK
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):789-796. PubMed ID: 31647558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dual Infection of Hepatitis A Virus and Hepatitis E Virus- What Is Known?
    Sayed IM
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
    Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
    Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.